Cipher Pharmaceuticals (PHE) Ownership - Who Owns Cipher Pharmaceuticals?
Cipher Pharmaceuticals (PHE) Ownership Overview
- 41.67% Insiders
- 0.93% Mutual Funds
- 2.59% Other Institutional Investors
- 0.16% ETFs
- 54.65% Public Companies and Individual Investors
The ownership structure of Cipher Pharmaceuticals (DE:PHE) stock is a mix of institutional, retail, and individual investors. Approximately 3.68% of the company’s stock is owned by Institutional Investors, 41.67% is owned by Insiders, and 54.65% is owned by Public Companies and Individual Investors.
The ownership structure of Cipher Pharmaceuticals (DE:PHE) stock is a mix of institutional, retail, and individual investors. Approximately 3.52% of the company’s stock is owned by Institutional Investors, 41.67% is owned by Insiders, and 0.16% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Mar 20, 2026 | Bryan Jacobs | C$129,600 | |
| Dec 01, 2025 | Bryan Jacobs | C$141,000 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Craig Mull | 10,576,103 | Insider | 41.61% | 95,988,711 |
| Advisors Series Trust | 224,700 | Institution | 0.88% | 2,039,377 |
| Dimensional | 32,139 | Institution | 0.13% | 291,694 |
| Dfa Investment Dimensions Group Inc | 11,058 | Institution | 0.04% | 100,362 |
| Bryan Jacobs | 9,087 | Insider | 0.04% | 82,474 |
| Tralucent | 8,817 | Institution | 0.03% | 80,023 |
| Hubert Walinski | 2,689 | Insider | 0.01% | 24,405 |
| Douglas Norman Deeth | 2,689 | Insider | 0.01% | 24,405 |
| Hotchkis & Wiley Funds/de/ | 1,000 | Institution | <0.01% | 9,076 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Advisors Series Trust | 224,700 | Institution | 0.88% | 2,039,377 |
| Dfa Investment Dimensions Group Inc | 11,058 | Institution | 0.04% | 100,362 |
| Hotchkis & Wiley Funds/de/ | 1,000 | Institution | <0.01% | 9,076 |
FAQ
Who Owns Cipher Pharmaceuticals (DE:PHE)?
According to the latest TipRanks data, approximately 2.59% of the company's stock is held by institutional investors, 41.67% is held by insiders, and 54.65% is held by retail investors.
What percentage of Cipher Pharmaceuticals (DE:PHE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.59% of Cipher Pharmaceuticals (DE:PHE) stock is held by institutional investors.
What percentage of Cipher Pharmaceuticals (DE:PHE) stock is held by retail investors?
According to the latest TipRanks data, approximately 54.65% of Cipher Pharmaceuticals (DE:PHE) stock is held by retail investors.
Who owns the most shares of Cipher Pharmaceuticals (DE:PHE)?
Craig Mull owns the most shares of Cipher Pharmaceuticals (DE:PHE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.